Expand QNRX Menu
QNRX MENU

QNRX Latest Press Releases

-- January 27, 2026 --

Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome Globe Newswire 8:30 AM

-- January 20, 2026 --

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome Globe Newswire 8:30 AM

-- November 11, 2025 --

Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies Globe Newswire 8:30 AM

-- November 6, 2025 --

Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results Globe Newswire 8:30 AM

-- October 30, 2025 --

Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025 Globe Newswire 8:30 AM

-- October 28, 2025 --

Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month 'Whole Body' Data Update from Ongoing Study Globe Newswire 8:30 AM

-- October 21, 2025 --

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome Globe Newswire 8:30 AM

-- October 10, 2025 --

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million Globe Newswire 9:24 AM

-- September 9, 2025 --

Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes